GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spectral Medical Inc (TSX:EDT) » Definitions » Retained Earnings

Spectral Medical (TSX:EDT) Retained Earnings : C$-129.60 Mil (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Spectral Medical Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Spectral Medical's retained earnings for the quarter that ended in Mar. 2024 was C$-129.60 Mil.

Spectral Medical's quarterly retained earnings declined from Sep. 2023 (C$-118.85 Mil) to Dec. 2023 (C$-125.44 Mil) and declined from Dec. 2023 (C$-125.44 Mil) to Mar. 2024 (C$-129.60 Mil).

Spectral Medical's annual retained earnings declined from Dec. 2021 (C$-98.49 Mil) to Dec. 2022 (C$-109.78 Mil) and declined from Dec. 2022 (C$-109.78 Mil) to Dec. 2023 (C$-125.44 Mil).


Spectral Medical Retained Earnings Historical Data

The historical data trend for Spectral Medical's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spectral Medical Retained Earnings Chart

Spectral Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only -80.61 -89.71 -98.49 -109.78 -125.44

Spectral Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -111.52 -115.46 -118.85 -125.44 -129.60

Spectral Medical Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Spectral Medical  (TSX:EDT) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Spectral Medical (TSX:EDT) Business Description

Traded in Other Exchanges
Address
135 - 2 The West Mall, Finance, Toronto, ON, CAN, M9C 1C2
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The company has one reporting segment Spectral Medical Inc. The Dialco Medical Inc. operations were considered discontinued by the company.
Executives
Anthony Phillip Bihl Director
William Charles Stevens Director

Spectral Medical (TSX:EDT) Headlines